Pathologic Myopia is a major cause of severe vision loss worldwide. The mechanisms for vision loss include cataract, glaucoma, retinal detachment, and above all, myopic maculopathy within the posterior staphyloma. The first edition of Pathologic Myopia is one of the only current books to specifically address this disease and discusses recent developments in imaging technologies and various approaches to treatments, such as laser photocoagulation, photodynamic therapy, pharmaco-therapeutic injections in the vitreous, and surgery. This new edition is a timely update to the standard reference in…mehr
Pathologic Myopia is a major cause of severe vision loss worldwide. The mechanisms for vision loss include cataract, glaucoma, retinal detachment, and above all, myopic maculopathy within the posterior staphyloma. The first edition of Pathologic Myopia is one of the only current books to specifically address this disease and discusses recent developments in imaging technologies and various approaches to treatments, such as laser photocoagulation, photodynamic therapy, pharmaco-therapeutic injections in the vitreous, and surgery. This new edition is a timely update to the standard reference in the field, with new chapters on advanced refractive error correction, genetics, developing a classification system, and special surgical approaches for pathologic myopia. Complete with even more high-quality color images and informative tables, this book is written and edited by leaders in the field and is geared towards ophthalmologists, including residents andfellows in training, glaucoma and cataract specialists, and vitreoretinal macula experts.
Richard F. Spaide, MD Vitreous, Retina, Macula Consultants of New York rick.spaide@gmail.com Kyoko Ohno-Matsui Department of Ophthalmology and Visual Science Tokyo Medical and Dental University k.ohno.oph@tmd.ac.jp Lawrence A. Yannuzzi, MD Professor of Clinical Ophthalmology College of Physicians and Surgeons Columbia University Founder, Director and President of The Macula Foundation, Inc. New York, NY, USA layannuzzi@gmail.com
Inhaltsangabe
Section 1 - Basic Science of Pathologic Myopia. .- Chapter 1. Myopia: A Historical Perspective.- Chapter 2. Definition of pathologic myopia (PM).- Chapter 3. Epidemiology of Myopia, High Myopia and Pathological Myopia.- Chapter 4. Genetics of Pathologic Myopia.- Chapter 5. Public Health Impact of Pathologic Myopia.- Chapter 6. Animal Models of Experimental Myopia: Limitations and Synergies with Studies on Human Myopia.- Chapter 7. The Sclera and its Role in Regulation of the Refractive State.- Section 2 - Ocular Changes in the Development of Pathologic Myopia. .- Chapter 8. Update on the Pathology of Pathological Myopia.- Chapter 9. The Sclera and Induced Abnormalities in Myopia.- Chapter 10. The Choroid Fin.- Chapter 11. Theories of Myopization: Potential Role of a Posterioly Expanding Bruch's Membrane .- Chapter 12. The Optic Nerve Head in High Myopia / Abnormalities of the Intrapapillary and Parapapillary Region.- Chapter 13. Vitreous Changes in Myopia.- Chapter 14. Ultra-widefield imaging of vitreous in pathologic myopia.- Section 3- Sequella of Pathologic Myopia and Their Potential Treatments. .- Chapter 15. Staphyloma I.- Chapter 16. Staphyloma II.- Chapter 17. Overview of OCT-based classification of macular lesions due to pathologic myopia.- Chapter 18. Myopic Maculopathy.- Chapter 19. Choroidal Neovascularization.- Chapter 20. Myopic Macular Retinoschisis.- Chapter 21. surgical approaches for complications of PM.- Chapter 22. Peripheral Retinal Abnormalities.- Chapter 23. Retinal Detachment.- Chapter 24. Glaucoma in Myopia.- Chapter 25. Myopic Optic Neuropathy.- Chapter 26. Special Considerations for Cataract Surgery in the Face of Pathologic Myopia.- Chapter 27. Ocular Motility Abnormalities.- Chapter 28. Ocular and Systemic Disease.- Section 4 - Treatment of pathologic myopia. .- Chapter 29. Prevention of myopia progression in children and adolescents.- Chapter 30. OPTICAL METHODS TO SLOW THE PROGRESSION OF MYOPIA.- Chapter 31. Sclera-targeted therapies for pathologic myopia.-
Section 1 - Basic Science of Pathologic Myopia. .- Chapter 1. Myopia: A Historical Perspective.- Chapter 2. Definition of pathologic myopia (PM).- Chapter 3. Epidemiology of Myopia, High Myopia and Pathological Myopia.- Chapter 4. Genetics of Pathologic Myopia.- Chapter 5. Public Health Impact of Pathologic Myopia.- Chapter 6. Animal Models of Experimental Myopia: Limitations and Synergies with Studies on Human Myopia.- Chapter 7. The Sclera and its Role in Regulation of the Refractive State.- Section 2 - Ocular Changes in the Development of Pathologic Myopia. .- Chapter 8. Update on the Pathology of Pathological Myopia.- Chapter 9. The Sclera and Induced Abnormalities in Myopia.- Chapter 10. The Choroid Fin.- Chapter 11. Theories of Myopization: Potential Role of a Posterioly Expanding Bruch's Membrane .- Chapter 12. The Optic Nerve Head in High Myopia / Abnormalities of the Intrapapillary and Parapapillary Region.- Chapter 13. Vitreous Changes in Myopia.- Chapter 14. Ultra-widefield imaging of vitreous in pathologic myopia.- Section 3- Sequella of Pathologic Myopia and Their Potential Treatments. .- Chapter 15. Staphyloma I.- Chapter 16. Staphyloma II.- Chapter 17. Overview of OCT-based classification of macular lesions due to pathologic myopia.- Chapter 18. Myopic Maculopathy.- Chapter 19. Choroidal Neovascularization.- Chapter 20. Myopic Macular Retinoschisis.- Chapter 21. surgical approaches for complications of PM.- Chapter 22. Peripheral Retinal Abnormalities.- Chapter 23. Retinal Detachment.- Chapter 24. Glaucoma in Myopia.- Chapter 25. Myopic Optic Neuropathy.- Chapter 26. Special Considerations for Cataract Surgery in the Face of Pathologic Myopia.- Chapter 27. Ocular Motility Abnormalities.- Chapter 28. Ocular and Systemic Disease.- Section 4 - Treatment of pathologic myopia. .- Chapter 29. Prevention of myopia progression in children and adolescents.- Chapter 30. OPTICAL METHODS TO SLOW THE PROGRESSION OF MYOPIA.- Chapter 31. Sclera-targeted therapies for pathologic myopia.-
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826